Institutional Ownership
Rigel Pharmaceuticals Inc Com
CUSIP 766559603StockRIGLQ1 2026
13D / 13G Filings
36
Schedule 13D/13G on record
Beneficial Filers
11
Distinct reporting persons
Largest Stake
14.4%
Max % of class reported
Institutional Holders
10
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
36 filings · latest Feb 14, 2024
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 14, 2024 | Armistice Capital, LLC | 13G/A | 9.8% | 17.10M | SEC |
| 2 | Feb 13, 2024 | Vanguard Group Inc | 13G/A | 5.1% | 8.95M | SEC |
| 3 | Feb 9, 2024 | Morgan Stanley | 13G | 8.3% | 14.49M | SEC |
| 4 | Feb 5, 2024 | Goldman Sachs Group Inc | 13G/A | 0.1% | 255.7K | SEC |
| 5 | Feb 2, 2024 | Soleus Capital Master Fund, L.P. | 13G/A | 5.4% | 9.44M | SEC |
| 6 | Jan 25, 2024 | Blackrock Inc. | 13G/A | 8.7% | 15.20M | SEC |
| 7 | Jun 12, 2023 | Fmr LLC | 13G/A | 0.1% | — | SEC |
| 8 | Feb 22, 2023 | Soleus Capital Master Fund, L.P. | 13G | 5.3% | 9.22M | SEC |
| 9 | Feb 14, 2023 | Armistice Capital, LLC | 13G | 9.8% | 16.96M | SEC |
| 10 | Feb 14, 2023 | Goldman Sachs Group Inc | 13G | 5.4% | 9.37M | SEC |
26 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Rigel Pharmaceuticals Inc Com.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Hughes Financial Services, LLC | 1.6K | $43.3K |
| 2 | Farther Finance Advisors, LLC | 752 | $20.7K |
| 3 | Advisory Services Network, LLC | 501 | $13.5K |
| 4 | Parallel Advisors, LLC | 340 | $9.2K |
| 5 | Versant Capital Management, Inc | 237 | $6.4K |
| 6 | Eversource Wealth Advisors, LLC | 218 | $5.9K |
| 7 | Bare Financial Services, Inc | 11 | $297 |
| 8 | Essential Partners LLC | 4 | $108 |
| 9 | Rothschild Investment LLC | 1 | $27 |
| 10 | Huntington National Bank | 1 | $1 |